Stanton R. Mehr

home / authors / stanton-r-mehr

Articles

October 21st 2014

The Intestinal Bug Hypothesis in Crohn's Disease Gets a Reboot

Stanton R. Mehr

October 21st 2014

The Economic Costs of Crohn's Disease

Stanton R. Mehr

October 14th 2014

Exploring the Intersection of Chronic Disease, Adherence, and Life Expectancy

Stanton R. Mehr Mary K. Caffrey

September 19th 2014

Recurrence of Breast Cancer Years After the Initial Tumor

Marj P. Zimmerman, MS, BSPharm Stanton R. Mehr

September 19th 2014

Upending of Conventional Combination Therapy in Type 2 Diabetes Mellitus

Stanton R. Mehr

September 19th 2014

Breast Cancer Survivorship Programs: More Than a Treatment

Marj P. Zimmerman, MS, BSPharm Stanton R. Mehr

August 25th 2014

Robotic-Assisted Surgery: A Question of Value

Stanton R. Mehr Marj P. Zimmerman, BSPharm, MS

July 21st 2014

Can Gastric Bypass Surgery Be a Cure for Diabetes Mellitus?

Stanton R. Mehr

May 21st 2014

Inhaled Insulin's Long Journey to Commercialization

Stanton R. Mehr

May 21st 2014

A Patient's Opinion of Unmet Need

Stanton R. Mehr

May 20th 2014

The How and Why of Stress, Diabetes, and the Brain

Stanton R. Mehr

A Visit With Mark Feinglos, MD, and Richard Surwit, PhD

April 22nd 2014

Increasing Access to HIV Care May Help Improve Outcomes

Marj P. Zimmerman, BSPharm, MS Stanton R. Mehr

March 19th 2014

Targeted Programmed Cell Death in Lung Cancer Treatment

Marj P. Zimmerman, MS, BSPharm Stanton R. Mehr

March 17th 2014

The Link Between a Common Type of Bariatric Surgery and Increased Alcohol Use

Stanton R. Mehr

March 17th 2014

The Continuing Evolution of Employer-Based Intervention in Diabetes Disease Management

Stanton R. Mehr

March 13th 2014

What Is the Place of New SGLT-2 Inhibitors in Therapy and on the Formulary?

Stanton R. Mehr Marj P. Zimmerman, BSPharm

February 11th 2014

Is Medicare Ready for Oncology Clinical Pathways?

Stanton R. Mehr

January 21st 2014

Attacking Complications to Kidney Problems in Diabetes: Atrial Fibrillation and Resistant Hypertension

Stanton R. Mehr

January 21st 2014

Nonincretin Drugs in Later-Stage Development

Marj P. Zimmerman, BSPharm, MS Stanton R. Mehr

October 22nd 2013

New Approaches to Medicaid Expansion: Hybrid Plans Offer Alternatives for Covering More People

Stanton R. Mehr Mary K. Caffrey

September 27th 2013

The Next Frontier for the Artificial Pancreas: Payer Coverage

Stanton R. Mehr

August 20th 2013

Sequester Forcing Chemo Treatments into Hospitals Costing Taxpayers More in the End

Stanton R. Mehr

July 2nd 2013

BMI and Beyond: Identifing Obesity in Patients at Risk for Diabetes and Heart Disease

Marj P. Zimmerman, MS, BSPharm Stanton R. Mehr

July 1st 2013

Innovations on the Horizon for the Treatment of Type 2 Diabetes An Interview With Javier Morales, MD

Stanton R. Mehr

May 7th 2013

Searching for Clinical and Economic Value in Pancreatic Cancer

Marj P. Zimmerman, MS, BS Pharm Stanton R. Mehr

May 7th 2013

Chemoprevention in Prostate Cancer: Identifying Patients at Greatest Risk May Provide Greatest Value

Marj P. Zimmerman, MS, BS Pharm Stanton R. Mehr

May 7th 2013

Applying Accountable Care to Oncology: Developing an Oncology ACO

Stanton R. Mehr

The cost-saving potential of specialty or disease-specific ACOs can be huge...but it is unclear whether these specialty services are more efficiently provided through their own ACO or as ancillary to the burgeoning primary care ACO marketplace.

May 7th 2013

Value-Based Contracting for Pharmaceuticals: Getting Ready for Prime Time?

Stanton R. Mehr

April 11th 2013

Is There a Business Case for Diabetes Disease Management?

Stanton R. Mehr

December 7th 2012

The Complexity of Covering Off-Label Use for a Multitude of Oncology Regimens

Stanton R. Mehr

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Long-Term Follow-Up from CheckMate 9LA at ASCO 2024

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Insights from the TROPION-Lung05 Trial at ASCO 2024

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School

Published: July 24th 2024 | Updated: July 27th 2024

Examining Trends, Future Directions in AI and Health Care

Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com

Published: July 15th 2024 | Updated: July 27th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Alfred L. Garfall, MD, an expert on multiple myeloma

Published: July 24th 2024 | Updated: July 27th 2024

Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions